Press release
Peptide Antibiotics Market Insights 2025-2034: Growth Forecast and Strategic Priorities
Peptide Antibiotics
Peptide Antibiotics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the peptide antibiotics market has seen a significant expansion lately. It is set to rise from $5.25 billion in 2024 to $5.82 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. This growth during the historic period can be credited to the progress and discovery of peptide antibiotics, a surge in antibiotic resistance, an increase in the occurrence of infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.
Peptide Antibiotics Market Size Forecast: What's the Projected Valuation by 2029?
The market for peptide antibiotics is predicted to experience significant expansion in the forthcoming years, with expected growth to $8.47 billion by 2029 at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth in the projected period include the accentuated focus on the creation of novel antibiotics, the rising worldwide occurrence of antibiotic-resistant infections, broadening research and development in the domain of antimicrobial peptides, and regulatory backing for new antibiotic approvals. Key trends foreseen throughout this period encompass probing natural sources for antimicrobial peptides, utilizing peptide antibiotics for animal health, focusing on peptide engineering for superior efficacy, devising combination peptide antibiotics, and incorporating artificial intelligence and machine learning into peptide antibiotic discovery.
View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
What Are the Drivers Transforming the Peptide Antibiotics Market?
The expected surge in the occurrence of multiple infectious diseases is forecasted to boost the peptide antibiotics market. These diseases are triggered by harmful microorganisms like bacteria, fungi, parasites and more. Factors such as rapid urbanization, climate alterations, escalating risks of disease outbreaks among others, have amplified the need for peptide antibiotics. These antibiotics play a crucial role in destroying the cell membranes and underpinning the antibacterial activity. For instance, the World Health Organization, a Switzerland-based intergovernmental organization, reported in May 2024, that in the American region, dengue cases had already surpassed seven million by April, a figure that's significantly higher than the 4.6 million cases reported the previous year. Thus, the escalation in the incidents of infectious diseases is fueling the growth of the peptide antibiotics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp
What Long-Term Trends Will Define the Future of the Peptide Antibiotics Market?
In the peptide antibiotics market, strategic collaborations have become a prevalent trend. Major players in this market are teaming up to broaden their market impact and capitalize on their combined resources. For instance, in January 2022, a partnership was formed between Berkeley Lights, an American digital cell biology firm, and Aanika Biosciences. Within this collaboration, Aanika will harness Berkeley Lights' high-capacity, functional screening service to quickly isolate and re-engineer antimicrobial peptides (AMPs) effective in killing harmful bacteria, notably the ones responsible for foodborne disease outbreaks. Also, they will use the Beacon Optofluidic Platform to pinpoint peptides toxic to bacteria and subsequently develop a unique antibacterial tag. This tag will then be incorporated into their bacterial spore-based barcoding technology to reinforce the safety of the food supply chain. Aanika Biosciences is a biotech firm based in the US.
Which Segments in the Peptide Antibiotics Market Offer the Most Profit Potential?
The peptide antibiotics market covered in this report is segmented -
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp
Which Firms Dominate the Peptide Antibiotics Market by Market Share and Revenue in 2025?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG
Which Regions Offer the Highest Growth Potential in the Peptide Antibiotics Market?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Antibiotics Market Insights 2025-2034: Growth Forecast and Strategic Priorities here
News-ID: 4081767 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
